✦ LIBER ✦

P-450 Gemcitabine-epidoxorubicin-cisplatin (GEP) as a new tripletcombination chemotherapy in patients with stage IIIB-IV non small cell lung cancer (NSCLC). A dose finding study

✍ Scribed by Barni, S.; Pronzato, P.; Cazzaniga, M.; Vigani, A.; Frontini, L.; Di Costanzo, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Gemcitabine and cisplatin as induction c

✍ Migliorino, M; De Marinis, F; Nelli, F; Facciolo, F; Ammaturo, M.V; Ramponi, S; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

P-6 A three drug combination chemotherap

✍ Tsalic, Medy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

P-562 Evaluation of bexarotene (Targreti

✍ Ramlau, R.; Zatloukal, P.; Tadokoro, H.; Jassem, J.; Hao, D.; Orlov, S.; Gottfri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II study of docetaxel (taxotere)

✍ Kim, H.K; Lee, K.S; Kim, J.S; Kim, Y.K; Park, H.S; Chung, T.J; Lee, S.N; Kang, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

225 Phase I–II study of high dose epidox

✍ Quantin, X.; Oliver, P.; Rivière, A.; Khial, F.; Madelaine, J.; Pujol, J.L. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 288 KB